New Biosketch Format Required: Use SciENcv to Make it Happen!

As of May 25, 2015, a new biosketch format will be required so why not get started sooner rather than later to address this change!  Science Experts Network Curriculum Vitae (SciENcv) has been developed as an option to save you time, now, and in the future, with the following automated features:

  • Pulls in your profile information from your eRA Commons account
  • Uploads your publications from My NCBI’s My Bibliography or your ORCID account (if you have one)
  • Allows you to create multiple versions of your profile by using information previously entered (reduces typing time!)   Continue reading

Songs4Sloan Benefit Concert for Pediatric Cancer Research at MSK and More…

  • On May 11 at 7pm at the Soho Playhouse (15 Vandam Street) in New York City, many of Broadway’s youngest stars will be performing as part of Songs4Sloan, a benefit concert presented by Abbey Rose Gould and Presley Ryan to benefit pediatric cancer research at MSK.
  • On April 12, MSK’s Patricia Skarulis delivered a keynote address at the College of Healthcare Information Management Executives spring forum in Chicago. MSK’s ever-evolving cybersecurity strategy was discussed, which currently includes a two-factor authentication for email and various initiatives to reduce the risk of having employees fall prey to increasingly sophisticated phishing schemes.
  • In an April 14 Annals of Internal Medicine paper, MSK’s Dr. Andrew Vickers, PhD, and Dr. David Kent of Tufts Medical Center argued that there may be a need for more individualized recommendations when it comes to screening and prevention as most individuals have below average risk and may experience more harm than benefit from unwarranted screenings.
  • From April 22-24, MSK will be the meeting site for a workshop hosted by the International Association for the Study of Lung Cancer (IASLC). In attendance will be 100 international experts on small cell lung cancer who will discuss the current state of knowledge in this field with the goal of developing a “roadmap for future research and clinical trials for patients with this disease”.

Dr. Lowy, Dr. Varmus, Cold Spring Harbor’s New Partner and More…

Here are a few highlights of cancer research news that have recently caught my attention:

  • Douglass Lowy has been named the Acting Director of the National Cancer Institute. Dr. Lowy’s areas of expertise includes: cancer biology papilloma viruses, preventive vaccines, and tumor suppressor genes. For more on his career.
  • New York Times writer Sabrina Tavernise recently interviewed Dr. Harold Varmus, former director of the National Cancer Institute. Dr. Varmus shared his thoughts on the state of cancer research and future trends.
  • Recently 60 Minutes on CBS aired a segment on a “miracle” treatment for glioblastoma which involves injecting the polio virus into the brains of patients. The study is currently being conducted at Duke. In response to the CBS piece, contributor Arlene Weintraub shared her thoughts in an article in Forbes.

Continue reading